Cambridge Investment Research Advisors’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-95
| Closed | -$18K | – | 3158 |
|
|
2022
Q2 | $18K | Buy |
+95
| New | +$18K | ﹤0.01% | 3007 |
|
|
2020
Q4 | – | Sell |
-78
| Closed | -$29K | – | 2782 |
|
|
2020
Q3 | $29K | Buy |
+78
| New | +$29K | ﹤0.01% | 2477 |
|
|
2018
Q3 | – | Sell |
-325
| Closed | -$147K | – | 2301 |
|
|
2018
Q2 | $147K | Sell |
325
-10
| -3% | -$4.52K | ﹤0.01% | 2067 |
|
|
2018
Q1 | $197K | Buy |
335
+7
| +2% | +$4.12K | ﹤0.01% | 1970 |
|
|
2017
Q4 | $204K | Buy |
328
+2
| +0.6% | +$1.24K | ﹤0.01% | 1911 |
|
|
2017
Q3 | $300K | Buy |
326
+43
| +15% | +$39.6K | ﹤0.01% | 1552 |
|
|
2017
Q2 | $264K | Buy |
+283
| New | +$264K | ﹤0.01% | 1585 |
|
|
2016
Q4 | – | Sell |
-163
| Closed | -$138K | – | 1805 |
|
|
2016
Q3 | $138K | Buy |
163
+4
| +3% | +$3.39K | ﹤0.01% | 1633 |
|
|
2016
Q2 | $131K | Sell |
159
-2
| -1% | -$1.65K | ﹤0.01% | 1454 |
|
|
2016
Q1 | $179K | Buy |
161
+65
| +68% | +$72.3K | ﹤0.01% | 1423 |
|
|
2015
Q4 | $120K | Sell |
96
-4
| -4% | -$5K | ﹤0.01% | 1469 |
|
|
2015
Q3 | $135K | Buy |
+100
| New | +$135K | ﹤0.01% | 1328 |
|